India bans 16 fixed-dose drug combinations over safety concernsIn a significant public health initiative, the ban on 16 fixed-dose drug combinations, including various antibiotics and topical formulatio...
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 27%As the market seems to be in comeback mode, it helps to be aware that the best (and probably biggest) wealth creator of the last couple of ...
Eli Lilly's Alzheimer's drug donanemab approved in India, but neurologists flag cost, access barriersA new drug for Alzheimer's, donanemab, has arrived in India. It aims to slow the disease's progression by clearing brain plaques. While off...
These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...
Zydus Semaglutide approval: Delhi HC directs CDSCO to decide on patient safety concernsThe Delhi High Court has asked the Central Drugs Standard Control Organisation to review a petition challenging Zydus Lifesciences' approva...
Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
Bio Medica Laboratories IPO: Check GMP, price band, subscription and other detailsBio Medica Laboratories' initial public offering begins subscription on Thursday. The company plans to raise Rs 52.43 crore through its IPO...
Roche brings 7-minute lung cancer shot to IndiaRoche Pharma India introduces a new injectable immunotherapy for lung cancer. This treatment takes only seven minutes, a significant reduct...
Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...
Mother's Day Special: How AI, apps are empowering women to manage finances, improve health, build careerWomen are learning to keep pace with the ubiquitous apps and AI, shrugging off dependence on their kids for financial transactions, online ...
Why Your Banana Peel Jar Isn’t Feeding Tomatoes the Way You ThinkWhile banana peels are rich in nutrients, simply soaking them in water for plant fertilizer is largely ineffective. Research indicates that...
India needs to reduce the strategic importance of fertilisers through a bold agricultural policyGlobal events like the West Asia conflict and El Nino threaten governments. Rising fertilizer prices create a fiscal and political crisis f...
Government prohibits 328 fixed dose combinationsThe ban is effective immediately and may shave off over Rs 1,500 crore from India’s Rs 1.18 lakh crore pharmaceutical industry
Companies challenge ban on fixed-dose combination drugsA Central government notification banning 344 such fixed-dose combinations in 2016 was set aside by the Delhi High Court in December.
NPPA backs ban on 'irrational' drugs, revises price fixation guidelinesIndia's drug pricing watchdog National Pharmaceutical Pricing Authority (NPPA) has moved in to back the health ministry.
Kerala HC gives chemists 2 more weeks to return 344 banned drugsThe Kerala HC has granted the state chemist and druggist association an extension to return the brands banned by a recent government order ...
Fixed- dose combos ban adds to burden of new essentials listAt least four drugmakers have rushed to court following the ban on more than 300 fixed-dose combination (FDC) medicines.